Ad5-nCoV Completed Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Prevention | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05313646 | Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults | |
| NCT04892459 | Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector) | |
| NCT04952727 | Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults | |
| NCT04833101 | Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine |